Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 5c; Trims FY12 EPS Range
Edwards Lifesciences Corp. (NYSE: EW) reported Q1 EPS of $0.53, $0.05 better than the analyst estimate of $0.48. Revenue for the quarter came in at $459.2 million versus the consensus estimate of $449.75 million.
Edwards Lifesciences Corp. sees FY2012 EPS of $2.58-$2.68, versus prior guidance of $2.70-$2.80 and the consensus of $2.67.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
Edwards Lifesciences Corp. sees FY2012 EPS of $2.58-$2.68, versus prior guidance of $2.70-$2.80 and the consensus of $2.67.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.